QQ客服 官方微博 反馈留言

	Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment
	Shi, Puyu; Oh, You Take; Zhang, Guojing; Yao, Weilong; Yue, Ping; Li, Yikun; Kanteti, Rajani; Riehm, Jacob; Salgia, Ravi; Owonikoko, Taofeek K.
刊名	CANCER LETTERS
	2016
卷号	380期号:[db:dc_citation_issue]页码:494-504
关键词	Bim EGFR Resistance AZD9291 Met Erlotinib
ISSN号	0304-3835
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3229597
专题	西安交通大学
推荐引用方式 GB/T 7714	Shi, Puyu,Oh, You Take,Zhang, Guojing,et al. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment[J]. CANCER LETTERS,2016,380([db:dc_citation_issue]):494-504.
APA	Shi, Puyu.,Oh, You Take.,Zhang, Guojing.,Yao, Weilong.,Yue, Ping.,...&Sun, Shi-Yong.(2016).Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.CANCER LETTERS,380([db:dc_citation_issue]),494-504.
MLA	Shi, Puyu,et al."Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment".CANCER LETTERS 380.[db:dc_citation_issue](2016):494-504.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。